复发性胶质瘤的临床病理特征及预后因素
该回顾性分析纳入2009至2018年在华西医院首次手术并复发的84例胶质瘤患者,分析影响复发时间和预后的因素。配对样本中O6-甲基鸟嘌呤-DNA甲基转移酶、异柠檬酸脱氢酶1和Ki-67差异有统计学意义。多因素分析显示初始世界卫生组织分级和Ki-67增殖指数是胶质瘤复发的独立预测因素。
要点
- 配对样本中MGMT、IDH1和Ki-67变化有统计学差异(P=0.013、0.014、0.017)。
- 单因素分析显示Ki-67、初始WHO分级、肿瘤侧别、年龄和切除程度与复发时间显著相关。
- 多因素分析显示初始WHO分级(HR=0.148)和Ki-67中表达(HR=0.256)是独立预测因素。
核心结论
- 初始世界卫生组织分级和Ki-67增殖指数是预测胶质瘤患者首次手术后复发时间的独立预后因素。
研究设计与样本
- 回顾性分析2009至2018年在华西医院首次手术并复发的胶质瘤患者的病理和临床资料,共84例纳入研究。
主要发现
- 配对样本统计分析显示O6-甲基鸟嘌呤-DNA甲基转移酶(阳性/阴性)、异柠檬酸脱氢酶1(阳性/阴性)和Ki-67差异有统计学意义(P=0.013、P=0.014、P=0.017)。
- 单因素分析显示Ki-67(低表达、中表达、高表达)、初始世界卫生组织分级(低级别或高级别)、肿瘤侧别(左侧、右侧、中间)、年龄(≥50岁、<50岁)和切除程度与复发时间显著相关(log-rank P=0.008、P<0.001、P=0.015、P<0.001、P=0.001)。
- 多因素分析显示Ki-67低表达(HR=0.585,95%CI=0.146-2.336,P=0.448)、中表达(HR=0.256,95%CI=0.084-0.784,P=0.017)和高表达(HR=1,作为参照)以及初始世界卫生组织分级(HR=0.148,95%CI=0.029-0.749,P=0.021)是胶质瘤复发的独立预测因素。
临床怎么用
- 原文未据此给出推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore related factors that influence time to recurrence and prognosis of gliomas. METHODS: A retrospective analysis of pathologic and clinical data of patients with glioma who underwent surgery for the first time and had a recurrence between 2009 and 2018 in West China Hospital was performed. Clinical characteristics of patients were reviewed, and survival analysis was performed to identify prognostic factors for the recurrent time. Molecules with differential changes in the paired samples were included in the survival analysis. RESULTS: A total of 84 patients met our inclusion requirements and were included in the study; other related factors were also considered in detail in the integrated analysis. Significant differences among O6-methylguanine-DNA methyltransferase (positive/negative), isocitrate dehydrogenase 1 (positive/negative), and Ki-67 were determined by statistical analysis of paired samples (P = 0.013, P = 0.014, P = 0.017). Univariate analysis demonstrated that Ki-67 (low expression, medium expression, high expression), initial World Health Organization grade (low or high), tumor side (left, right, middle), age (≥50 years, <50 years), and extent of resection were significantly correlated with time to recurrence (log-rank P = 0.008, P < 0.001, P = 0.015, P < 0.001, P = 0.001). Multivariate analysis results showed that Ki-67 lower expression (hazard ratio [HR] = 0.585, 95% confidence interval [CI] = 0.146-2.336, P = 0.448), medium expression (HR = 0.256, 95% CI = 0.084-0.784, P = 0.017), and high expression (HR = 1 as a reference) together with the initial World Health Organization grade (HR = 0.148, 95% CI = 0.029-0.749, P = 0.021) were independent predictive factors for glioma recurrence. CONCLUSIONS: This comprehensive analysis revealed that initial World Health Organization grade and Ki-67 proliferative index were independent prognostic factors that predict the time to recurrence of glioma in patients after first surgery.
引用
- Li J, Niu X, Gan Y, et al. Clinical and Pathologic Features and Prognostic Factors for Recurrent Gliomas. World Neurosurg. 2019. PMID: 30880199. doi:10.1016/j.wneu.2019.02.210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。